Why aren't amphetamines commonly used for cancer-related fatigue?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18627593
Cited by: 0

Abstract

Amphetamines are not commonly used for cancer-related fatigue due to their high potential for abuse and severe adverse effects, alongside a lack of supporting efficacy evidence in this context.

Fields of Study & Subjects

Cancer survivorship and care Pain Management and Opioid Use Cancer-related cognitive impairment studies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
11 February 2026
Language
EN